Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zuogui Yin is a classic traditional Chinese medicine (TCM) formula originally recorded in the "Jingyue Quanshu" (Complete Works of Jingyue) by Zhang Jingyue. It is primarily used to nourish Kidney Yin and replenish essence. The formula typically consists of six herbs: *Rehmannia glutinosa* (Shu Di Huang), *Dioscorea opposita* (Shan Yao), *Cornus officinalis* (Shan Zhu Yu), *Lycium barbarum* (Gou Qi Zi), *Poria cocos* (Fu Ling), and *Glycyrrhiza uralensis* (Gan Cao). In modern clinical practice, it is frequently investigated for its efficacy in treating perimenopausal syndrome, particularly when characterized by kidney deficiency. It is often used in combination with other formulas, such as Chaihu Sugan San, to address complex patterns involving both liver depression and kidney deficiency. Clinical studies, including Phase 0 trials, have evaluated its safety and efficacy in modulating hormonal balance and alleviating menopausal symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zuogui yin.